|
Volumn 11, Issue 2, 2017, Pages 221-228
|
Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions
|
Author keywords
CHST15; Crohn s disease; mucosal healing
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
CHONDROITIN SULFATE;
CHST15 PROTEIN, HUMAN;
GASTROINTESTINAL AGENT;
MEMBRANE PROTEIN;
SMALL INTERFERING RNA;
SULFOTRANSFERASE;
ANTAGONISTS AND INHIBITORS;
BIOPSY;
BIOSYNTHESIS;
CONTROLLED STUDY;
CROHN DISEASE;
DOSE RESPONSE;
DRUG EFFECTS;
DRUG MONITORING;
ENDOSCOPIC MUCOSAL RESECTION;
FEMALE;
FIBROSIS;
HUMAN;
INTESTINE MUCOSA;
INTRALESIONAL DRUG ADMINISTRATION;
MALE;
METABOLISM;
PATHOLOGY;
PATIENT ACUITY;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
BIOPSY;
CHONDROITIN SULFATES;
CROHN DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
ENDOSCOPIC MUCOSAL RESECTION;
FEMALE;
FIBROSIS;
GASTROINTESTINAL AGENTS;
HUMANS;
INJECTIONS, INTRALESIONAL;
INTESTINAL MUCOSA;
MALE;
MEMBRANE GLYCOPROTEINS;
OLIGORIBONUCLEOTIDES, ANTISENSE;
PATIENT ACUITY;
RNA, SMALL INTERFERING;
SULFOTRANSFERASES;
TREATMENT OUTCOME;
|
EID: 85018977783
PISSN: None
EISSN: 18764479
Source Type: Journal
DOI: 10.1093/ecco-jcc/jjw143 Document Type: Article |
Times cited : (42)
|
References (0)
|